07. Topical steroids

Resident Editor: Juliana Macri, M.D..

Faculty Editor: Ryan Arakaki, M.D.

Background

  • Class refers to the strength of topical steroids and is determined by both potency and vehicle.
  • The steroid class selected depends on the affected body part and the condition being treated (lower classes on the face or intertriginous areas; higher classes on the extremities, hands, or feet)
  • Indications for topical steroids include conditions with hyperproliferation, inflammation, and immunologic involvement. Topical steroids also relieve burning and pruritic symptoms
  • Use on a fungal infection will exacerbate the condition, so perform a skin scraping with KOH before prescribing. Avoid anti-fungal – steroid combination

Steroid vehicles and application:

  • Ointments:
  • Petroleum-based, greasy (patients often dislike)
  • Better for hydration, occlusion, and absorption
  • Useful for dry, thick, hyperkeratotic lesions
  • Avoid hairy and intertriginous areas (can cause skin maceration and folliculitis)
  • Creams:
  • Water suspended in oil
  • More cosmetically acceptable but less potent than ointments
  • Drying effect
  • Often contain preservatives (which can irritate and cause an allergic reaction)
  • Lotions:
  • Minimally greasy and occlusive
  • Contain alcohol (drying effect good for oozing lesions, may cause stinging/burning)
  • Useful for hairy and intertriginous areas given good penetration with minimal residue
  • Gels:
  • Alcohol-based with a jelly-like consistency
  • Dries quickly
  • Useful for hairy or oily areas (like scalp) or wet lesions (bullae)
  • Application tips
  • Hydration and occlusion promote steroid penetration
  • Applying after bathing improves the effectiveness
  • Occlusion with plastic wrap can increase penetration several-fold (good for extremities). Recommend using overnight, but not on the face or intertriginous areas, and shortening duration of use

Side Effects From Topical Steroids

  • Atrophic changes (increased risk with higher potency, occlusion, thin skin, and age)
  • Easy bruising, increased fragility, striae, ulceration
  • Can be mitigated by concurrent topical tretinoin (Retin-A) 0.1% if chronic use required (though difficult to adhere to, not commonly used)
  • Infections (especially if inappropriate treatment of fungal or bacterial infection)
  • Aggravation of cutaneous infection, masked infection (tinea incognito), secondary infections
  • Re-evaluate diagnosis if the rash worsens or does not improve with steroids
  • Miscellaneous
  • Contact dermatitis (often due to additives, rarely can have an allergy to the steroid agent itself)
  • Steroid-induced acne, rosacea
  • Delayed wound healing
  • Hypertrichosis (hirsutism)
  • Hypopigmentation
  • Systemic effects
  • High-dose steroids may have enough absorption to cause systemic effects (e.g. hypertension, hyperglycemia, glaucoma) and HPA axis suppression, especially when used on a broken skin barrier.

Prescribing Considerations

  • Consider generic availability and patient’s formulary to increase adherence. Counsel patient to reach out for alternative if cost-prohibitive.
  • Must consider potency, frequency, and duration of therapy
  • Potency
  • Low potency steroids preferred for long-term use, large surface areas, on the face, intertriginous areas, and other areas with thinner skin
  • High potency steroid can be used in severe disease, areas with thicker skin (e.g. palms, soles). Never use on face, intertriginous areas. Caution with occlusion.
  • Frequency
    • Once or twice daily for most preparations. Titrate to a minimum frequency that still provides relief
  • Duration
    • Be aware of side effects, tolerance, and tachyphylaxis with prolonged use
    • Do not use ultra-high potency for >3 weeks at a time. Use intermittent schedule with tapering and one-week steroid-free interval, as needed
    • Low-high potency steroids should be limited to <3 months. Shorter if with occlusion or on thin skin.
    • Anticipate the amount required for appropriate treatment and prescribe accordingly (see Table 8).

Table 7: Classes of Topical Steroids

Note: common preparations in bold

Class

Potency

Indication

Generic

Brand

1

Ultra High

Severe, unresponsive inflammatory dermatoses

Do not use >3 weeks;  never use on face or groin

Clobetasol propionate 0.05%

Betamethasone dipropionate 0.05%

Fluocinonide 0.1%

Clobex, Temovate®

Diprolene®

Vanos

 

2

Very High

Severe inflammatory dermatoses (e.g., severe atopic or contact dermatitis, psoriasis)

Desoximetasone 0.25%, 0.05%

Fluocinonide 0.05%

Topicort®

Lidex®

3

Medium to High

Moderate dermatoses

Triamcinolone acetonide 0.5%

Fluticasone propionate 0.005%

Amcinonide 0.1%

Cinalog®

Cutivate®

Cyclocort®

4, 5

Medium

Moderate dermatoses

Betamethasone valerate 0.1%, 0.12%

Desoximetasone 0.05%

Flucoinolone acetnoide 0.025%

Fluticasone propionate 0.05%

Hydrocortisone butyrate 0.1%

Hydrocortisone valerate 0.2%

Mometasone furoate 0.1%

Triamcinolone acetonide 0.05%, 0.1%

Beta-Val® 0.1%, Luxiq® 0.12%

Topicort LP®

Synalar®

Cutivate®

Locoid®

Westcort®

Elocon®

Triderm®

6

Low

Mild dermatoses

Desonide 0.05%

Fluocinolone 0.01%

Hydrocortisone butyrate 0.1%

Desonate®

 

Locoid®

7

Least potent

Very mild, self-limiting dermatoses

Hydrocortisone 1%, 2.5%

 

Fingertip Unit

1 FTU = 0.5g = Amount that can be squeezed from the fingertip to the first crease of the finger

 

Enough to cover 2 hands (one side) worth of skin

Face and neck = 2.5 FTU

Trunk (front or back) = 7 FTU

Arm = 3 FTU

Leg = 6 FTU

Foot = 2 FTU

 

Table 8: Required Steroid Amount/Week

Body Area

Quantity (grams)

Face and neck

15-30

Scalp

15-30

Both hands

15-30

Groin and genitalia

15-30

Both arms

30-60

Both legs

100

Trunk

100

 

References

Miller, JA, Munro DD.  Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs 1980;19:119.

Ference JD, Last AR. Choosing Topical Corticosteroids. Am Fam Physician. 2009;79(2):135-140.